Back to Search
VICTOR RIVERA, M.D.
M.D.
General Practice Physician
NPI: 1396199303IndividualAccepts Medicare
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
ACN1144(FL)19320(PR)
CMS Specialties
PrimaryGENERAL PRACTICE
Education
SAN JUAN BAUTISTA SCHOOL OF MEDICINE
Class of 2014
Research & Publications (20)
Exocytosis of post-Golgi vesicles is regulated by components of the endocytic machinery.
PMID 19563761·Cell·2009
8-other
Quantitative detection of staphylococcal enterotoxin B by resonant acoustic profiling.
PMID 19374426·Anal Chem·2009
8-other
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.
PMID 19228743·Clin Cancer Res·2009
3-trial
Photoreduction of Cr(VI) using hydroxoaluminiumtricarboxymonoamide phthalocyanine adsorbed on TiO2.
PMID 19424532·Photochem Photobiol Sci·2009
8-other
Change in quantitative human chorionic gonadotropin after manual vacuum aspiration in women with pregnancy of unknown location.
PMID 19168172·Am J Obstet Gynecol·2009
8-other
Longitudinal and axial stability of a cementless metaphyseal versus a fully porous coated cylindrical femoral stem.
PMID 19602338·J Surg Orthop Adv·2009
4-observational
A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide.
PMID 18815156·Rheumatology (Oxford)·2009
3-trial
Multiple sclerosis in Latin America: reality and challenge.
PMID 19246934·Neuroepidemiology·2009
8-other
Ligamentous laxity of the knee during childhood and adolescence.
PMID 18388713·J Pediatr Orthop·2008
8-other
Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies.
PMID 18202410·J Clin Oncol·2008
3-trial
Identification of the RNA N-glycosidase activity of ricin in castor bean extracts by an electrochemiluminescence-based assay.
PMID 18394420·Anal Biochem·2008
8-other
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies.
PMID 18451242·Clin Cancer Res·2008
3-trial
Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer.
PMID 17245354·Mol Ther·2007
7-preclinical
Real-time PCR Quantification and Mycotoxin Production of Fusarium graminearum in Wheat Inoculated with Isolates Collected from Potato, Sugar Beet, and Wheat.
PMID 18943932·Phytopathology·2007
8-other
Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndrome.
PMID 16624483·Clin Neurol Neurosurg·2007
5-case
A quantitative electrochemiluminescence assay for Clostridium perfringens alpha toxin.
PMID 16949539·Anal Biochem·2006
8-other
Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon.
PMID 16769975·Neurology·2006
8-other
An activity-dependent assay for ricin and related RNA N-glycosidases based on electrochemiluminescence.
PMID 16942744·Anal Biochem·2006
8-other
Cu2{[18]ane-N6} complexes: structures, magnetism, and phosphate monoester binding.
PMID 16961393·Inorg Chem·2006
8-other
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.
PMID 17263005·Mult Scler·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1 Calle Baldorioty
Caguas, PR 00725 - Phone
- (787) 406-6214
Quick Facts
- NPI
- 1396199303
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile